SCHEMBL4564389

SCHEMBL4564389

CCOC(=O)Nc1nc2cc(C(=O)C3(Cc4ccccc4)C=CC=CC3C(=O)O)ccc2o1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RAF1 P04049 2/20 0.49
▸ BRAF P15056 1/20 0.49
▸ NPC1 O15118 7/20 0.41
▸ RAB9A P51151 7/20 0.41
▸ TP53 P04637 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HDAC6 Q9UBN7 6/20 0.38
▸ IL6 P05231 1/20 0.37
▸ STAT3 P40763 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ GLA P06280 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ AGPAT2 O15120 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15640908 0.74 LMNA (0.48) RAF1BRAFNPC1RAB9ATP53
SCHEMBL3021481 0.73 RAF1 (0.67) RAF1BRAFNPC1RAB9ATP53
SCHEMBL1467043 0.73 RAF1 (0.86) RAF1BRAFNPC1RAB9ATP53
SCHEMBL4564390 0.71 RAF1 (0.61) RAF1BRAFNPC1RAB9ATP53
SCHEMBL14097676 0.70 SMN1; SMN2 (0.58) RAF1BRAFNPC1RAB9ATP53
SCHEMBL31430624 0.62 LCK (0.57) NPC1RAB9ATP53SMN1; SMN2HDAC6
SCHEMBL31430564 0.59 LCK (0.56) NPC1RAB9ATP53SMN1; SMN2HDAC6
SCHEMBL24894178 0.59 NPC1 (0.61) RAF1BRAFNPC1RAB9ATP53
SCHEMBL30194619 0.59 NPC1 (0.61) RAF1BRAFNPC1RAB9ATP53
SCHEMBL5369888 0.59 THRB (0.57) HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101759-B1 METHODS OF USING MEK INHIBITORS EXELIXIS INC (US) 2018-10-10 — — EP claimed
US-8697737-B2 Raf modulators and methods of use EXELIXIS, INC. (US) 2014-04-15 — — US claimed
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 — — WO claimed
Send feedback